Researchers from Ann & Robert H. Lurie Children’s Hospital of Chicago were among the multicenter team of experts who determined more accurate national estimates of non-neonatal pediatric sepsis using readily available clinical data from electronic health records. As they recently reported in JAMA, sepsis occurred in 1.3% of pediatric hospitalizations, with 10% mortality rate, corresponding to more than 18,000 U.S. cases and more than 1,800 deaths annually. Neither pediatric sepsis incidence nor mortality changed significantly from 2016 to 2022.

About The Study: This cross-sectional study of patients with de novo metastatic breast cancer (dnMBC) found racial and ethnic disparities in disease presentation and inequities in timely treatment for dnMBC across subtypes, emphasizing the need for tailored interventions to improve care delivery and outcomes. De novo metastatic breast cancer, defined as the presence of distant metastases at initial diagnosis, accounts for only 5.4% to 10.0% of new cases but disproportionately contributes to breast cancer mortality in the U.S.

Researchers have developed a new methodology that uses artificial intelligence (AI) tools to identify and count target viruses more efficiently than previous techniques. The new approach can be used in applications such as pharmaceutical biomanufacturing.

New research shows there's no need to 'go hard' at the gym to become fitter and stronger.

Over the years, scientific research has led to the development of several pharmacological therapies for this disease. Now, a study coordinated by the University of Trento (Italy) marks a turning point, as it identified a gene therapy for individuals with cystic fibrosis caused by a specific mutation and for whom there was no treatment available until now. They are about 10% of all those with the disease. The results open up further prospects because they could lead to a definitive cure for patients with cystic fibrosis who are currently dependent on drugs.